Breast cancer chemoprevention: progress and controversy.

Surgical Oncology Clinics of North America
D Lawrence Wickerham

Abstract

The chemoprevention of breast cancer using pharmacologic agents has had substantial clinical success. Randomized clinical trials evaluating selective estrogen-receptor modulators (SERMs) have shown that these agents reduce the incidence of breast cancer by up to 50% in healthy women at increased risk for the development of the disease. SERMs have been of particular value in women with biopsy-proven risk factors, including atypical hyperplasia or lobular carcinoma in situ of the breast. The agents of established value are important options for women today, and efforts are under way to identify additional more effective therapies.

References

Nov 14, 1997·Science·W K Hong, M B Sporn
Jan 14, 1999·The New England Journal of Medicine·L C HartmannR B Jenkins
Nov 17, 2001·JAMA : the Journal of the American Medical Association·M C KingUNKNOWN National Surgical Adjuvant Breast and Bowel Project
Aug 1, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Rowan T ChlebowskiUNKNOWN American Society of Clinical Oncology Breast Cancer Technology Assessment Working Group
Jun 19, 2003·Journal of the National Cancer Institute·Sylvie MénardAndrea Balsari
Dec 2, 2004·Journal of the National Cancer Institute·Silvana MartinoUNKNOWN CORE Investigators
Feb 22, 2007·Journal of the National Cancer Institute·Jack CuzickUNKNOWN International Breast Cancer Intervention Study I Investigators
Feb 22, 2007·Journal of the National Cancer Institute·Trevor J PowlesMitch Dowsett
May 29, 2009·CA: a Cancer Journal for Clinicians·Ahmedin JemalMichael J Thun

❮ Previous
Next ❯

Citations

Feb 10, 2012·Expert Review of Anticancer Therapy·Emmanuel M Gabriel, Ismail Jatoi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.

Carcinoma, Lobular

Lobular carcinoma is an invasive type of breast cancer in which lobules, areas of the breast that produce milk, undergo malignant transformation. Here is the latest research.

Related Papers

Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progrès Dans Les Recherches Sur Le Cancer
Trevor Powles
American Journal of Surgery
S M Rosenbaum Smith, M P Osborne
© 2021 Meta ULC. All rights reserved